News

US FDA centers to deploy AI internally, following experimental run
The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...
U.S. FDA approves Verastem's cancer therapy
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a type of ovarian cancer ...
Novavax swings to profit, says talks with FDA on COVID vaccine approval ongoing
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
OpenAI and US FDA hold talks about using AI in drug evaluation, Wired reports
OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...
Exclusive: US cancels FDA bargaining session over layoffs, union says
The Trump administration last week canceled the first bargaining session scheduled with the U.S. Food and Drug Administration ...
US FDA names agency critic Vinay Prasad as top vaccine official
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
Trump to sign order on drug prices as early as next week, Politico reports
U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to ...
Hikma Pharma to pay $50 million to settle narcolepsy drug antitrust case
Hikma Pharmaceuticals has agreed to pay $50 million to settle a class action accusing the drugmaker of scheming to delay a generic version of Jazz’s blockbuster narcolepsy drug Xyrem, causing health ...
Novo Nordisk's CFO sceptical Trump executive order on drug manufacturing can cut timelines
Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...
Exclusive: US FDA asks some fired pharma user fee negotiation staff to return
The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...
Drug maker Recordati's Q1 revenue rises 11.9%, confirms 2025 guidance
Italian drug maker Recordati posted an 11.9% increase in its first-quarter net revenue on Thursday to 680.0 million euros ($767.52 million) and confirmed its guidance for 2025.